Franklin Resources Inc. Buys 32,852 Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Franklin Resources Inc. grew its stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 12.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 289,131 shares of the company's stock after purchasing an additional 32,852 shares during the quarter. Franklin Resources Inc. owned approximately 0.78% of Crescent Capital BDC worth $5,557,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. C M Bidwell & Associates Ltd. bought a new stake in Crescent Capital BDC during the 4th quarter valued at $39,000. LPL Financial LLC raised its holdings in shares of Crescent Capital BDC by 10.0% in the 4th quarter. LPL Financial LLC now owns 24,437 shares of the company's stock worth $470,000 after purchasing an additional 2,230 shares in the last quarter. Condor Capital Management lifted its position in shares of Crescent Capital BDC by 4.7% during the 4th quarter. Condor Capital Management now owns 284,055 shares of the company's stock valued at $5,460,000 after acquiring an additional 12,852 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Crescent Capital BDC during the fourth quarter worth $661,000. Finally, Raymond James Financial Inc. purchased a new stake in shares of Crescent Capital BDC during the fourth quarter valued at $3,750,000. 49.46% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CCAP. Wells Fargo & Company cut their price objective on Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a report on Friday, February 21st. Keefe, Bruyette & Woods decreased their price objective on shares of Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating for the company in a research note on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $18.90.

Crescent Capital BDC Price Performance

Shares of CCAP remained flat at $15.20 on Wednesday. The stock had a trading volume of 30,165 shares, compared to its average volume of 141,896. The firm has a market cap of $563.34 million, a price-to-earnings ratio of 7.63 and a beta of 0.56. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32. The stock's 50 day moving average is $17.47 and its 200-day moving average is $18.47. Crescent Capital BDC, Inc. has a 1-year low of $13.54 and a 1-year high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The business had revenue of $46.40 million for the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. As a group, equities research analysts forecast that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The business also recently declared a dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a $0.05 dividend. The ex-dividend date was Friday, February 28th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 84.42%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.